Talk to Sam

+1 718 618 4302

data types

Biotherapeutics Market and Forecasts, May 2013

You might be interested in: clinical trial, cancer, protein, more »


 
1-10 of about 200 reports for Biotherapeutics
Biosimilar Market Analysis  in The United States and Japan

Biosimilar Market Analysis in The United States and Japan

  • Industry report
  • May 2013
  • 62 pages

... Management plan is fundamental for all biotherapeutic products since even minor differences in the manufacturing process may affect the efficacy and/or safety profile Innovator products Biosimilar may ...

Pharmaceutical Sector  in The United States and Israel

Pharmaceutical Sector in The United States and Israel

  • Industry report
  • December 2011
  • 6 pages
  • by Corporation

... Event reported): december 1, 2011 protalix biotherapeutics, inc. (Exact name of registrant as specified in its charter) florida 001-33357 65-0643773 (state or other jurisdiction (commission file ...

The Chinese Biopharmaceutical Business Brief

The Chinese Biopharmaceutical Business Brief

  • Industry report
  • December 2011
  • 7 pages

... Perspectives on partnering to capture china S biosimilar/ biologics opportunities Can biotherapeutics sales growth trend continue on a larger scale Which domestic players are leaders today and can ...

Blood Sector in Canada

Blood Sector in Canada

  • Industry report
  • April 2012
  • 3 pages

... Products manufactured by grifols (formerly talecris biotherapeutics), csl behring and baxter corporation to meet the expected demand for this year. Purchasing immune globulin products from multiple ...

The Indian Biogeneric Sector Brief

The Indian Biogeneric Sector Brief

  • Industry report
  • October 2011
  • 6 pages

... To produce biotherapeutics in an emerging country such as india is often one of the greatest limiting factors. This is primarily due to complications related to manufacturing biologics as well as issues ...

The South Korean Biosimilar Sector

The South Korean Biosimilar Sector

  • Industry report
  • May 2011
  • 21 pages
  • by Intergovernmental Agency

... Explained the scope and important key definitions such as sbp, reference biotherapeutic products (rbp) and the importance of using appropriate terminology. The guideline advocates the principle of a step ...

U.S. Biotechnology Industry Brief

U.S. Biotechnology Industry Brief

  • Industry report
  • April 2012
  • 4 pages

... A wining cgmp facility design for manufacturing of biotherapeutics biological products commercialization process commercialization of biotherapeutics products is a complex process which starts ...

The Chinese Biopharmaceutical Business : Innovation and Technology Trends

The Chinese Biopharmaceutical Business : Innovation and Technology Trends

  • Industry report
  • March 2012
  • 10 pages

... Koenig, ceo, macrogenics 1530 afternoon tea break biotherapeutics closing plenary workshop 1600-1700 glycosylation as a strategy to improve antibody-based therapeutics to date, more than 20 ...

U.S. Biotechnology Industry Brief

U.S. Biotechnology Industry Brief

  • Industry report
  • April 2012
  • 4 pages

... Of biotherapeutics products is a complex process which starts from mammalian cell line development and engineering and going through various phases of development such as early stage process ...

Blood Product Business  in Italy and The United States

Blood Product Business in Italy and The United States

  • Industry report
  • August 2012
  • 2 pages

... That grifols will exit the melville factory in about two years. Grifols, based in barcelona, spain, sold the plant to satisfy federal antitrust concerns over its 2011 merger with talecris biotherapeutics ...

» Read our Company Profiles

2 Companies for Biotherapeutics

Citrix

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.